| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12,462 |
11,850 |
$418K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,596 |
3,199 |
$322K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,234 |
15,626 |
$259K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
6,350 |
5,262 |
$218K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,203 |
8,914 |
$200K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
7,886 |
7,024 |
$199K |
| 0225U |
|
1,612 |
1,377 |
$160K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
2,231 |
1,831 |
$146K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,310 |
1,216 |
$118K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,442 |
2,155 |
$113K |
| 87428 |
|
2,282 |
1,801 |
$70K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,021 |
2,691 |
$69K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,117 |
6,012 |
$62K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,531 |
4,627 |
$48K |
| 99000 |
|
17,180 |
14,440 |
$37K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
4,574 |
3,542 |
$28K |
| 99072 |
|
15,374 |
12,553 |
$12K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,353 |
1,236 |
$12K |
| 91320 |
|
196 |
184 |
$9K |
| 0124A |
|
232 |
229 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
410 |
367 |
$6K |
| 90480 |
|
384 |
364 |
$5K |
| 0134A |
|
163 |
158 |
$5K |
| 91322 |
|
136 |
136 |
$3K |
| 99051 |
|
2,515 |
2,191 |
$3K |
| 81025 |
|
2,640 |
2,551 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
394 |
374 |
$3K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
152 |
152 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
25 |
24 |
$2K |
| 99215 |
Prolong outpt/office vis |
90 |
87 |
$2K |
| 90686 |
|
82 |
82 |
$1K |
| A4267 |
Contraceptive supply, condom, male, each |
231 |
222 |
$1K |
| 0004A |
|
96 |
95 |
$1K |
| 81000 |
|
910 |
865 |
$1K |
| 93000 |
|
204 |
201 |
$1K |
| 90756 |
|
48 |
48 |
$939.13 |
| 0002A |
|
241 |
241 |
$866.39 |
| 99205 |
Prolong outpt/office vis |
27 |
27 |
$809.49 |
| 0064A |
|
43 |
43 |
$804.29 |
| 0053A |
|
27 |
27 |
$797.60 |
| 36415 |
Collection of venous blood by venipuncture |
2,340 |
2,116 |
$578.06 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
128 |
127 |
$451.11 |
| 0001A |
|
218 |
215 |
$450.00 |
| 0072A |
|
64 |
61 |
$438.18 |
| 0054A |
|
12 |
12 |
$380.64 |
| 0071A |
|
70 |
69 |
$369.38 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
113 |
110 |
$259.63 |
| 90688 |
|
14 |
14 |
$221.06 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
86 |
80 |
$210.33 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
24 |
23 |
$180.41 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
56 |
55 |
$120.42 |
| S9083 |
Global fee urgent care centers |
225 |
209 |
$105.34 |
| 99173 |
|
254 |
252 |
$80.75 |
| 81002 |
|
1,049 |
1,007 |
$76.12 |
| G0008 |
Administration of influenza virus vaccine |
25 |
24 |
$60.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
13 |
$24.94 |
| 88150 |
|
2,919 |
2,912 |
$22.89 |
| 82962 |
|
71 |
56 |
$7.92 |
| 99385 |
|
52 |
52 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
301 |
294 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
72 |
72 |
$0.00 |
| 99199 |
Unlisted special service, procedure or report |
29 |
29 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$0.00 |